Has Brummitte Wilson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,061 in general payments to Brummitte Wilson, MD across 45 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brummitte Wilson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brummitte Wilson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brummitte Wilson, MD

MOHS-Micrographic Surgery · Hamburg, NYNPI 1245237288

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 34.2% of the total. Reporting peaked in 2019 at $344 and has fallen 64.4% since, to $123 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in NY, where the typical reported total is $1,291.

$1,061in general payments, 2019–2025

Across 45 payments — averaging $23.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$362
Sun Pharmaceutical Industries Inc.$186
E.r. Squibb & Sons, L.L.C.$144
Novartis$71
Lilly USA, LLC$52
Pfizer$47
plus $198 from 9 others

What the payments were for

Food & beverage$1,061100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	14	$362
Sun Pharmaceutical Industries Inc.	4	$186
E.r. Squibb & Sons, L.L.C.	2	$144
Novartis	4	$71
Lilly USA, LLC	3	$52
Pfizer	3	$47
Sanofi	2	$39
UCB, Inc.	2	$35
Helsinn Therapeutics (U.S.), Inc.	2	$26
Amgen	1	$22
Prugen, Inc. Pharmaceuticals	4	$19
Genentech USA, Inc.	1	$17
Incyte Corporation	1	$15
Johnson & Johnson	1	$14
Galderma Laboratories, L.p.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Sotyktu$123
Humira$118

How this compares

$1,061 in reported general payments places this provider in the 45th percentile of 75 mohs-micrographic surgery providers in New York.

See all mohs-micrographic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$286,702

Medicare patients

372

Services billed

1,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluorouracil	53	$2,993
Calcipotriene	19	$2,443
Mupirocin	326	$2,307
Fluocinonide	54	$1,946
Tretinoin	18	$1,614
Azelaic Acid	16	$1,532
ValacyclovirValacyclovir Hcl	56	$1,456
Ketoconazole	59	$1,274
Metronidazole	12	$850
Clobetasol Propionate	12	$638
Imiquimod	23	$513
Hydrocortisone Valerate	14	$437
Clindamycin Phosphate	11	$381
Cephalexin	126	$295
Triamcinolone Acetonide	30	$223

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Hamburg

Andrew SauvageauHamburg$1K
Daniel SiegelSmithtown$450K
Sherrif IbrahimVictor$412K
Kavita MariwallaWest Islip$221K
Ellen MarmurNew York$186K
Kenneth MarkSouthampton$91K
Michael TassavorNew York$55K
Jane YooNew York$42K
Hamza BhattiNew York$40K
Desiree RatnerNew York$32K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →